Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smartwatches for seniors: a new way to boost activity?

NCT ID NCT06287255

Knowledge-focused Sponsor: Ohio State University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether giving Fitbit smartwatches to adults aged 65 and older in a doctor-referred exercise program can help them become more active. Researchers will track how many people join, attend, and complete the program, and how they feel about using the watch. The goal is to see if this technology is a good fit for helping older adults stay healthy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2024

Expected to finish

May 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 65+ * No healthcare provider-imposed limitations on physical activity * English-speaking Exclusion Criteria: * Symptoms suggestive of coronary artery disease (CAD) or congestive heart failure (CHF) (i.e. chest pain, dizziness, syncope, excessive dyspnea on exertion) * Myocardial infarction within the last 12 months * Revascularization within the last 12 months * Stroke/transient ischemic attack (TIA) within the past 12 months * Unstable angina * Congestive heart failure (New York Heart Association (NYHA) Class II, III or IV) * Ventricular arrhythmia * Clinically significant cardiac valve disease * Blood pressure \>160/100 mmHg * Uncontrolled seizure disorder * Major surgery within the past three months * Severe or frequent hypoglycemia * Inability to independently manage blood glucose during activity * Severe autonomic or peripheral neuropathy * Active foot ulcers * Unstable retinopathy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obesity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Sedentary Behavior

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Obesity Physical inactivity

Contacts and locations

Locations

  • The Ohio State University

    Columbus, Ohio, 43202, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.